TABLE 1.
Group | Animal | Statusa
|
|||||
---|---|---|---|---|---|---|---|
1st challenge (45)
|
2nd challenge
|
3rd challenge
|
|||||
Homologous SHIV strain | Outcome | Heterologous, nonvirulent SHIV strain | Outcome | Related, highly virulent SHIV strain | Outcome | ||
A | 9143 | W6.1D | Protected | han2 | Protected | 89.6p | Infected |
9157 | W6.1D | Protected | sf13 | Protected | 89.6p | Infected | |
9172 | W6.1D | Infected | sf13 | (prot, W6.1D) | 89.6p | (prot, W6.1D) | |
9206 | W6.1D | Infected | han2 | Transient | 89.6p | Infected | |
B | 9150 | W6.1D | Protected | han2 | Infected | 89.6p | (prot, han2) |
9175 | W6.1D | Protected | sf13 | Transient | 89.6p | Infected | |
9214 | W6.1D | Protected | sf13 | Transient | 89.6p | Infected | |
9208 | W6.1D | Protected | han2 | Protected | 89.6p | Infected | |
C | 9171 | W6.1D | Protected | han2 | Protected | 89.6p | Infected |
9203 | W6.1D | Protected | sf13 | Protected | 89.6p | Infected | |
9205 | W6.1D | Protected | han2 | Protected | 89.6p | Protected | |
9241 | W6.1D | Protected | sf13 | Protected | 89.6p | Infected | |
D | AA002 | W6.1D | Infected | ||||
J040 | W6.1D | Infected | |||||
L146 | W6.1D | Infected | |||||
Y005 | W6.1D | Infected | |||||
K7D | han2 | Infected | |||||
KXO | han2 | Infected | |||||
KKO | sf13 | Infected | |||||
VC1 | sf13 | Infected | |||||
BJC | 89.6p | Infected | |||||
WT5 | 89.6p | Infected |
For explanation of boldface, see Results.